List view / Grid view
An assay is an analytical procedure in laboratory medicine, pharmacology and molecular biology for measuring the activity of a target entity.
This technical note gives you critical insights into on how to run, optimise and validate this ERK assay on your own cellular materials...
Starting in the 1970s, the drug discovery research process changed dramatically. Our understanding of biological targets and pathways grew and the largely empirical and target agnostic in vivo pharmacology approach was replaced with target-centric methods...
4 August 2016 | By Bio-Rad Laboratories
The Bio-Plex System offers high-performance readers, industry-leading software, and sensitive assays in ready-to-use or custom configurations, enabling you to obtain high-quality data from limited samples...
4 August 2016 | By Bio-Rad Laboratories
The CFX96™ Optical Reaction Module converts the C1000 Touch™ Thermal Cycler chassis into the powerful and precise CFX96 Touch Real-Time PCR Detection System...
28 July 2016 | By IntelliCyt Corporation
Robust mix and read kits for cell- and bead-based screening applications...
This whitepaper highlights how commercial tools can reduce assay development time and enable a biologic developer to get to market or submission before competitors...
28 June 2016 | By Merck KGaA
EMD Millipore is continually developing and refining tools and technologies for the study of neuroscience. Researchers can count on our comprehensive portfolio of dependable, high-quality solutions for elucidating questions related to neuroscience...
16 June 2016 | By Drug Target Review
Drug Target Review talks to Joseph Jammal, Chief Operating Officer of Cisbio Bioassays, to find out more about assay developments and future innovations in this area of drug discovery...
15 June 2016 | By Merck KGaA
We offer an extensive, focused portfolio of antibodies and immunoassays, including validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins...
2 June 2016 | By Merck KGaA
EMD Millipore’s extensive portfolio of validated antibodies help unravel the complexities of stem cell research...
10 May 2016 | By Merck KGaA
Complete product portfolio for the study of cell structure, intracellular signaling, extracellular environment, and cellular migration and invasion...
28 April 2016 | By Merck KGaA
Each of EMD Millipore’s ChIPAb+™ and RIPAb+™ antibodies are validated and tested for ChIP and RNA immunoprecipitation (RIP)...
12 April 2016 | By Merck KGaA
As a leading provider of antibodies for cell signaling research, EMD Millipore is advancing life science research and therapeutic development...
17 March 2016 | By Merck KGaA
EMD Millipore offers an extensive, focused portfolio of immunoassays and validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins...
In this Assays In-Depth Focus: "Finding a cure for neglected tropical diseases with cell-based assays", plus "The relevance of homogeneous radiometric assays in modern drug discovery"...
